CASI Pharmaceuticals Inc. (NASDAQ: CASI) Stock Information | RedChip

CASI Pharmaceuticals Inc. (NASDAQ: CASI)


$2.7500
+0.1000 ( -3.07% ) 0.1K

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

Market Data


Open


$2.7500

Previous close


$2.6500

Volume


0.1K

Market cap


$40.97M

Day range


$2.8370 - $2.8370

52 week range


$2.0500 - $8.1900

SEC Filings


Form Type Description Pages Date
6-k Form 6-K 3 Mar 28, 2024
20-f Annual reports 152 Mar 28, 2024
6-k Form 6-K 1 Mar 13, 2024
6-k Form 6-K 1 Feb 29, 2024
6-k Form 6-K 1 Feb 12, 2024
6-k Form 6-K 1 Jan 30, 2024
6-k Form 6-K 1 Dec 15, 2023
6-k Form 6-K 1 Dec 08, 2023

Latest News